Studies

Photo

News • Gender equality in clinical trials

Women in Covid-19 research: a good start, but...

There has been a "positive shift" in inclusive gender practices in Covid-19 vaccine research, but there is still room for improvement, experts say. Women have been equally recruited and represented in randomised control trial research about Covid-19 vaccine safety, efficacy and effectiveness, according to a new study by The George Institute for Global Health and The Australian National…

Photo

Video • Prevention of triple-negative BRCA

Breast cancer vaccine: clinical trial started

Researchers from Cleveland Clinic have opened a novel study for a vaccine aimed at eventually preventing triple-negative breast cancer, the most aggressive and lethal form of the disease. This phase I trial is designed to determine the maximum tolerated dose of the vaccine in patients with early-stage triple-negative breast cancer and to characterize and optimize the body’s immune response. The…

Photo

News • Neurology research

Stroke: Women remain underrepresented in clinical trials

A new study shows that women are underrepresented in stroke clinical trials relative to the number who have strokes in the general population. The research is published in Neurology, the medical journal of the American Academy of Neurology. “Making sure there are enough women in clinical studies to accurately reflect the proportion of women who have strokes may have implications for future…

Photo

News • Combined chemotherapy

Pancreatic cancer: New treatment promising for older patients

Pancreatic cancer is a disease of the elderly: the average age of patients is 72. In Austria, about 1,600 people are diagnosed each year. Since pancreatic cancer has no specific symptoms, it is not usually diagnosed until the tumor is locally advanced or has already metastasized. Once the tumor has metastasized, it is usually no longer treatable by surgery or radiotherapy. In addition, the drug…

Photo

News • Medication combination

'4-in-1' blood pressure pill shows great promise

The first large-scale, long-term trial of a new strategy using combinations of very low-doses in one capsule, has demonstrated significantly improved control of high blood pressure - the leading cause of heart attack and stroke. This first large-scale, randomised controlled clinical trial of starting this novel combination blood pressure medication brought blood pressure under control in 80…

Photo

News • More nurses, less ventilation and medication

A new approach to improve outcomes for critically-ill children

A major UK clinical trial led by Queen’s University Belfast has shown how a new approach to reduce the use of mechanical ventilation can greatly improve outcomes for critically ill infants and children. The study, funded by the National Institute for Health Research (NIHR) Health Technology Programme, found that a greater involvement of nurses, minimising sedation use and increasing daily…

Photo

News • Heart-related hospitalisations

Drug danger: opioid use linked to steep rise in cardiac arrests

A nationwide US study has shown that the rate of opioid-related cardiac arrests has steeply risen and is now on par with the rate of cardiac arrest from other causes. The research is presented at ESC Congress 2021. Opioid use disorder, which includes dependence and addiction, affects more than two million people in the US, while opioid overdose is the leading cause of death for those aged 25 to…

Photo

News • Antisense therapy update

Huntington's disease: setback for study of promising agent

Roche announced the decision to discontinue dosing in the Phase III GENERATION HD1 study of tominersen (previously IONIS-HTTRx and RG6042) in manifest Huntington’s disease (HD). The decision was based on the results of a pre-planned review of the data from the Phase III study conducted by an unblinded Independent Data Monitoring Committee (iDMC). The iDMC made its recommendation based on the…

Photo

News • Data analysis tool

Blockchain app to optimise clinical trials

A new blockchain-based data analysis app aims to drive collaboration and insights across clinical trials. The tool, developed by software company Clintex, is designed to boost trial efficiency, help drive down the cost of new medicines and expediting their delivery to patients.

Photo

News • Orthopaedics

Iliac crest reconstruction: 15 patients recruited into GreenBRIC study

GreenBone Ortho, a company specialising in bone regeneration, announces that it has achieved its aim of recruiting 15 patients into the GreenBRIC study. GreenBRIC study is a prospective, open label, single-arm, First-in-Human clinical investigation, in male and female patients, aged between 18 and 70 years, undergoing surgery to correct bone defects using GreenBone Implant, specifically for iliac…

Photo

News • Software solution

Using AI to match cancer patients to early phase clinical trials

Cancer informatics and digital pathology provider Inspirata announced that King’s Health Partners ECMC and Guy’s and St Thomas’ NHS Foundation Trust will pilot its Trial Navigator software as part of an evaluation the organisations are conducting into how artificial intelligence based automation can improve the identification and efficiency of matching patients with cancer to early phase…

Photo

News • Coronavirus and the sexes

Covid-19 clinical trials ignore gender differences

Although the coronavirus affects men and women differently, the vast majority of clinical trials do not mention sex/gender, a new analysis of 4,420 studies concludes. Ultimately, it can influence the treatment negatively. The meta analysis is published in Nature Communications. According to the new research, only 4 percent of 4,420 registered studies explicitly plan to address sex and gender in…

Photo

News • Analysis of 2nd and 3rd Corona wave

Rapid tests effectively contain Covid-19

Rapid tests effectively broke Covid-19 infection chains in spring 2021. This is shown by a model developed by researchers of the ECONtribute: Markets & Public Policy Cluster of Excellence of the Universities of Bonn and Cologne, the Collaborative Research Center Transregio 224 EPoS of the Universities of Bonn and Mannheim, and the Institute for the Study of Labor (IZA). According to the…

Photo

News • Study on devices and implants

AI could improve speech recognition in hearing aids

In noisy environments, it is difficult for hearing aid or hearing implant users to understand their conversational partner because current audio processors still have difficulty focusing on specific sound sources. In a feasibility study, researchers from the Hearing Research Laboratory at the University of Bern and the Inselspital are now suggesting that artificial intelligence (AI) could solve…

459 show more articles
Subscribe to Newsletter